Epithelial-mesenchymal plasticity (EMP) refers to the ability of cells to dynamically
interconvert between epithelial (E) and mesenchymal (M) phenotypes, thus generating an …

The epithelial–mesenchymal transition (EMT) is a biological phenomenon associated with
explicit phenotypic and molecular changes in cellular traits. Unlike the earlier-held popular …

Epithelial mesenchymal transition (EMT) is a complex process through which epithelial (E)
cells lose their adherens junctions, transform into mesenchymal (M) cells and attain motility …

Epithelial-to-mesenchymal transition (EMT) is a cellular program which leads to cells losing
epithelial features, including cell polarity, cell–cell adhesion and attachment to the basement …

Cancer cells can acquire a spectrum of stable hybrid epithelial/mesenchymal (E/M) states
during epithelial–mesenchymal transition (EMT). Cells in these hybrid E/M phenotypes often …

Cancer metastasis and therapy resistance are the major unsolved clinical challenges, and
account for nearly all cancer-related deaths. Both metastasis and therapy resistance are …

Stem cells have self-renewal capacities and the ability to give rise to differentiated cells
thereby sustaining tissues during homeostasis and injury. This structural hierarchy extends …

Simple Summary Cancer spreading into different organs, or cancer metastasis, remains the
major clinical problem in almost all cancer types. Cancer metastasis is known to be …

Epithelial–mesenchymal transition (EMT) is a fundamental process that occurs during
embryogenesis and tissue repair. However, EMT can be hijacked by malignant cells, where …

The epithelial-mesenchymal (E/M) hybrid state has emerged as an important mediator of
elements of cancer progression, facilitated by epithelial mesenchymal plasticity (EMP). We …